Cargando…

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults

OBJECTIVE: Research in animals has shown that chronic stress exacerbates tau pathology. In humans, psychological stress has been associated with higher risk of Alzheimer disease clinical syndrome. The objective of this cross-sectional study was to assess the hypothesis that stress coping ability (as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arenaza-Urquijo, Eider M., Przybelski, Scott A., Machulda, Mary M., Knopman, David S., Lowe, Val J., Mielke, Michelle M., Reddy, Ashritha L., Geda, Yonas E., Jack, Clifford R., Petersen, Ronald C., Vemuri, Prashanthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251516/ https://www.ncbi.nlm.nih.gov/pubmed/31964689 http://dx.doi.org/10.1212/WNL.0000000000008979

Ejemplares similares

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology
por: Ramanan, Vijay K., et al.
Publicado: (2021)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity
por: Carvalho, Diego Z., et al.
Publicado: (2022)

Brain amyloid, cortical thickness, and changes in activities of daily living
por: Vassilaki, Maria, et al.
Publicado: (2020)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Improving the resistance and resilience framework for aging and dementia studies
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
por: Ramanan, Vijay K, et al.
Publicado: (2019)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
por: Neth, Bryan J., et al.
Publicado: (2020)

Variants in PPP2R2B and IGF2BP3 are associated with higher tau deposition
por: Ramanan, Vijay K, et al.
Publicado: (2020)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele
por: Ghisays, Valentina, et al.
Publicado: (2020)

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
por: Vassilaki, Maria, et al.
Publicado: (2023)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

(1)H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
por: Nedelska, Zuzana, et al.
Publicado: (2017)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

Optimizing quantification of MK6240 tau PET in unimpaired older adults
por: Harrison, Theresa M., et al.
Publicado: (2023)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Amyloid- and tau-PET imaging in a familial prion kindred
por: Jones, David T., et al.
Publicado: (2018)

FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2016)

Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
por: Blackman, Jonathan, et al.
Publicado: (2022)

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
por: Nedelska, Zuzana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2k0hv2obe3df3f87ukiv6lephg